364 related articles for article (PubMed ID: 2542829)
1. Role of alpha-adrenergic mechanism in effects of morphine on the hypothalamo-pituitary-adrenocortical and cardiovascular systems in the rat.
Suemaru S; Dallman MF; Darlington DN; Cascio CS; Shinsako J
Neuroendocrinology; 1989 Feb; 49(2):181-90. PubMed ID: 2542829
[TBL] [Abstract][Full Text] [Related]
2. Catecholaminergic mediation of morphine-induced activation of pituitary-adrenocortical axis in the rat: implication of alpha- and beta-adrenoceptors.
Martinez-Piñero MG; Milanés MV; Alcaraz C; Vargas ML
Brain Res; 1994 Dec; 668(1-2):122-8. PubMed ID: 7704598
[TBL] [Abstract][Full Text] [Related]
3. Interrelationships of opioidergic and adrenergic mechanisms controlling the secretion of corticotrophin releasing factor in the rat.
Buckingham JC; Cooper TA
Neuroendocrinology; 1987 Sep; 46(3):199-206. PubMed ID: 2821423
[TBL] [Abstract][Full Text] [Related]
4. Changes in catecholaminergic pathways innervating paraventricular nucleus and pituitary-adrenal axis response during morphine dependence: implication of alpha(1)- and alpha(2)-adrenoceptors.
Laorden ML; Fuertes G; González-Cuello A; Milanés MV
J Pharmacol Exp Ther; 2000 May; 293(2):578-84. PubMed ID: 10773031
[TBL] [Abstract][Full Text] [Related]
5. Involvement of amygdalar alpha adrenoceptors in hypothalamo-pituitary-adrenocortical responses.
Feldman S; Weidenfeld J
Neuroreport; 1996 Nov; 7(18):3055-7. PubMed ID: 9116239
[TBL] [Abstract][Full Text] [Related]
6. Effect of adrenergic antagonists and cyclooxygenase inhibitors on the nicotine-induced hypothalamic-pituitary-adrenocortical activity.
Gadek-Michalska A; Bugajski J; Bugajski AJ; Głód R
J Physiol Pharmacol; 2002 Jun; 53(2):275-87. PubMed ID: 12120902
[TBL] [Abstract][Full Text] [Related]
7. Effects of naloxone on hypothalamo-pituitary-adrenocortical activity in the rat.
Buckingham JC; Cooper TA
Neuroendocrinology; 1986; 42(5):421-6. PubMed ID: 3010154
[TBL] [Abstract][Full Text] [Related]
8. Catecholaminergic regulation of the hypothalamic-pituitary-adrenocortical activity.
Bugajski J; Turoń M; Gadek-Michalska A; Borycz JA
J Physiol Pharmacol; 1991 Mar; 42(1):93-103. PubMed ID: 1681965
[TBL] [Abstract][Full Text] [Related]
9. Involvement of GABAB receptors in the regulation of the hypothalamo-pituitary-adrenocortical (HPA) axis in rats.
Häusler A; Monnet G; Peter O
J Steroid Biochem Mol Biol; 1993 Dec; 46(6):767-71. PubMed ID: 8274410
[TBL] [Abstract][Full Text] [Related]
10. Adrenergic regulation of the hypothalamic-pituitary-adrenal axis under basal and social stress conditions.
Bugajski J; Gadek-Michalska A; Ołowska A; Borycz J; Głód R; Bugajski AJ
J Physiol Pharmacol; 1995 Sep; 46(3):297-312. PubMed ID: 8527811
[TBL] [Abstract][Full Text] [Related]
11. Effects of receptor blockers (methysergide, propranolol, phentolamine, yohimbine and prazosin) on desimipramine-induced pituitary hormone stimulation in humans--III. Hypothalamo-pituitary-adrenocortical axis.
Laakmann G; Wittmann M; Schoen HW; Zygan K; Weiss A; Meissner R; Mueller OA; Stalla GK
Psychoneuroendocrinology; 1986; 11(4):475-89. PubMed ID: 3031718
[TBL] [Abstract][Full Text] [Related]
12. Monoamine mediation of cocaine-induced hypothalamo-pituitary-adrenal activation.
Borowsky B; Kuhn CM
J Pharmacol Exp Ther; 1991 Jan; 256(1):204-10. PubMed ID: 1671094
[TBL] [Abstract][Full Text] [Related]
13. Differences in hypothalamo-pituitary-adrenocortical activity in the rat after acute and prolonged treatment with morphine.
Buckingham JC; Cooper TA
Neuroendocrinology; 1984 May; 38(5):411-7. PubMed ID: 6328347
[TBL] [Abstract][Full Text] [Related]
14. The muscarinic cholinergic agonist arecoline stimulates the rat hypothalamic-pituitary-adrenal axis through a centrally-mediated corticotropin-releasing hormone-dependent mechanism.
Calogero AE; Kamilaris TC; Gomez MT; Johnson EO; Tartaglia ME; Gold PW; Chrousos GP
Endocrinology; 1989 Nov; 125(5):2445-53. PubMed ID: 2551652
[TBL] [Abstract][Full Text] [Related]
15. Chronic brain glucocorticoid receptor blockade enhances the rise in circadian and stress-induced pituitary-adrenal activity.
van Haarst AD; Oitzl MS; Workel JO; de Kloet ER
Endocrinology; 1996 Nov; 137(11):4935-43. PubMed ID: 8895366
[TBL] [Abstract][Full Text] [Related]
16. Nitric oxide mediates the interleukin-1beta- and nicotine-induced hypothalamic-pituitary-adrenocortical response during social stress.
Gadek-Michalska A; Bugajski J
J Physiol Pharmacol; 2005 Sep; 56(3):491-503. PubMed ID: 16204770
[TBL] [Abstract][Full Text] [Related]
17. Basal and PAF-, interleukin 1-, ether stress-induced hypothalamic pituitary adrenal secretion of conscious rat: modulation by PAF antagonists.
Rougeot C; Tiberghein C; Minary P; Dray F
J Lipid Mediat; 1991; 4(1):45-59. PubMed ID: 1654152
[TBL] [Abstract][Full Text] [Related]
18. Morphine withdrawal activates hypothalamic-pituitary-adrenal axis and heat shock protein 27 in the left ventricle: the role of extracellular signal-regulated kinase.
Martínez-Laorden E; Hurle MA; Milanés MV; Laorden ML; Almela P
J Pharmacol Exp Ther; 2012 Sep; 342(3):665-75. PubMed ID: 22647273
[TBL] [Abstract][Full Text] [Related]
19. Secretion of growth hormone elicited by intravenous desipramine in the conscious, unrestrained rat.
Grealy M; O'Donnell JM
Br J Pharmacol; 1991 Feb; 102(2):369-72. PubMed ID: 1849767
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological manipulations of alpha-adrenoceptors in the infant rat and effects on growth hormone secretion. Study of the underlying mechanisms of action.
Cella SG; Locatelli V; De Gennaro V; Wehrenberg WB; Müller EE
Endocrinology; 1987 Apr; 120(4):1639-43. PubMed ID: 2881775
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
